These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30233431)

  • 21. Acetaldehyde-mediated increase in glutamatergic and N-acetylaspartate neurometabolite levels in the midcingulate cortex of ALDH2*1/*2 heterozygous young adults.
    Ueno F; Sakuma M; Nakajima S; Tsugawa S; Ochi R; Tani H; Noda Y; Graff-Guerrero A; Uchida H; Mimura M; Oshima S; Matsushita S
    Alcohol Clin Exp Res (Hoboken); 2024 Jan; 48(1):58-71. PubMed ID: 38206287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain GABA and Glutamate Concentrations Following Chronic Gabapentin Administration: A Convenience Sample Studied During Early Abstinence From Alcohol.
    Meyerhoff DJ; Murray DE; Durazzo TC; Pennington DL
    Front Psychiatry; 2018; 9():78. PubMed ID: 29599727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and drinking outcomes among patients with comorbid alcohol dependence and borderline personality disorder treated with high-dose baclofen: a comparative cohort study.
    Rolland B; Valin T; Langlois C; Auffret M; Gautier S; Deheul S; Danel T; Bordet R; Cottencin O
    Int Clin Psychopharmacol; 2015 Jan; 30(1):49-53. PubMed ID: 25356633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A preliminary examination of cortical neurotransmitter levels associated with heavy drinking in posttraumatic stress disorder.
    Pennington DL; Abé C; Batki SL; Meyerhoff DJ
    Psychiatry Res; 2014 Dec; 224(3):281-7. PubMed ID: 25444536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [GABAB receptor as therapeutic target for drug addiction: from baclofen to positive allosteric modulators].
    Agabio R; Colombo G
    Psychiatr Pol; 2015; 49(2):215-23. PubMed ID: 26093587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose baclofen for the treatment of alcohol dependence (BACLAD study): a randomized, placebo-controlled trial.
    Müller CA; Geisel O; Pelz P; Higl V; Krüger J; Stickel A; Beck A; Wernecke KD; Hellweg R; Heinz A
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1167-77. PubMed ID: 26048580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical pathology in brain white matter of recently detoxified alcoholics: a 1H magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injury.
    Schweinsburg BC; Taylor MJ; Alhassoon OM; Videen JS; Brown GG; Patterson TL; Berger F; Grant I
    Alcohol Clin Exp Res; 2001 Jun; 25(6):924-34. PubMed ID: 11410730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of high-dose baclofen on cue reactivity in alcohol dependence: A randomized, placebo-controlled pharmaco-fMRI study.
    Beck A; Pelz P; Lorenz RC; Charlet K; Geisel O; Heinz A; Wüstenberg T; Müller CA
    Eur Neuropsychopharmacol; 2018 Nov; 28(11):1206-1216. PubMed ID: 30217552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and side effects of baclofen and the novel GABA
    Vengeliene V; Takahashi TT; Dravolina OA; Belozertseva I; Zvartau E; Bespalov AY; Spanagel R
    Psychopharmacology (Berl); 2018 Jul; 235(7):1955-1965. PubMed ID: 29651507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of alcohol and tobacco use on in vivo glutathione in youth with bipolar disorder: an exploratory study.
    Chitty KM; Lagopoulos J; Hickie IB; Hermens DF
    J Psychiatr Res; 2014 Aug; 55():59-67. PubMed ID: 24755258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety.
    O'Malley SS; Corbin WR; Leeman RF; DeMartini KS; Fucito LM; Ikomi J; Romano DM; Wu R; Toll BA; Sher KJ; Gueorguieva R; Kranzler HR
    J Clin Psychiatry; 2015 Feb; 76(2):e207-13. PubMed ID: 25742208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baclofen and severe alcohol dependence: an uncertain harm-benefit balance as of early 2013.
    Prescrire Int; 2013 Sep; 22(141):214-7. PubMed ID: 24171218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated Glutamate Levels in the Left Dorsolateral Prefrontal Cortex Are Associated with Higher Cravings for Alcohol.
    Frye MA; Hinton DJ; Karpyak VM; Biernacka JM; Gunderson LJ; Geske J; Feeder SE; Choi DS; Port JD
    Alcohol Clin Exp Res; 2016 Aug; 40(8):1609-16. PubMed ID: 27439218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Double blind placebo controlled randomized pilot clinical trial of baclofen (Baclosan®) for alcohol dependence].
    Krupitsky EM; Rybakova KV; Kiselev AS; Alexeeva YV; Berntsev VA; Chekhlaty EI; Zubova EY; Popov YV; Neznanov NG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(6):53-62. PubMed ID: 26356398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain metabolite levels in recently sober individuals with alcohol use disorder: Relation to drinking variables and relapse.
    Zahr NM; Carr RA; Rohlfing T; Mayer D; Sullivan EV; Colrain IM; Pfefferbaum A
    Psychiatry Res Neuroimaging; 2016 Apr; 250():42-9. PubMed ID: 27035062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The positive effects of high-frequency right dorsolateral prefrontal cortex repetitive transcranial magnetic stimulation on memory, correlated with increases in brain metabolites detected by proton magnetic resonance spectroscopy in recently detoxified alcohol-dependent patients.
    Qiao J; Jin G; Lei L; Wang L; Du Y; Wang X
    Neuropsychiatr Dis Treat; 2016; 12():2273-2278. PubMed ID: 27695332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolite profiles in the anterior cingulate cortex of depressed patients differentiate those taking N-acetyl-cysteine versus placebo.
    Das P; Tanious M; Fritz K; Dodd S; Dean OM; Berk M; Malhi GS
    Aust N Z J Psychiatry; 2013 Apr; 47(4):347-54. PubMed ID: 23341476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.
    Namkoong K; Lee BO; Lee PG; Choi MJ; Lee E
    Alcohol Alcohol; 2003; 38(2):135-41. PubMed ID: 12634260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): study protocol for a randomised controlled trial.
    Morley KC; Leung S; Baillie A; Haber PS
    Contemp Clin Trials; 2013 Nov; 36(2):348-55. PubMed ID: 23939511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topiramate for treating alcohol dependence: a randomized controlled trial.
    Johnson BA; Rosenthal N; Capece JA; Wiegand F; Mao L; Beyers K; McKay A; Ait-Daoud N; Anton RF; Ciraulo DA; Kranzler HR; Mann K; O'Malley SS; Swift RM; ;
    JAMA; 2007 Oct; 298(14):1641-51. PubMed ID: 17925516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.